Herbst, R.S., Prager, D., Hermann, R., et al. (2005) TRIBUTE: A Phase Ⅲ Trial of Erlotinib Hydrochloride (OSI2774) Combined with Carbop Latin and Paclitaxel Chemotherapy in Advanced Non-Small-Cell Lung Cancer. Journal of Clinical Oncology, 23, 5892-5899.

相关文章:
在线客服:
对外合作:
联系方式:400-6379-560
投诉建议:feedback@hanspub.org
客服号

人工客服,优惠资讯,稿件咨询
公众号

科技前沿与学术知识分享